H26.9
Conditions
Interventions
Group 1: On patients with cataract a trifocal PanOptix intraocular lens will be bilaterally implanted. A four week distance will be kept between the two operations.
Group 2: On patients with cataract
Sponsors
MVZ RHR Augenärzte GmbH Düsseldorf
Eligibility
Sex/Gender
All
Age
50 Years to 81 Years
Inclusion criteria
Inclusion criteria: 1. Patients with cataract in both eyes and with a medical indication of a cataract extraction with an implantation of an artificial lens. All the patients have voluntarily and independent from the study decided for a unilateral or bilateral implantation of a trifocal Acrysof IQ PanOptix lens, after a medical enlightenment talk with the treated ophthalmologist. Only capable of consent adults will be included in the study. 2. Age 50-81. 3. No other eye disease. 4. No refractive operation in the patient history. 5. No secondary cataract or already treated secondary cataract with YAG-Laser Kapsulotomy by the time of the evaluation 3 months after the second operation.
Exclusion criteria
Exclusion criteria: 1. Missing patient consent 2. Presence of other eye diseases 3. Postoperative complications that affect the visual aquity 4. Necessity for a re-operation 5. No appearance for the postoperativ evaluation (follow-up).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study´s primary ending point is the patients´visual function and their satisfaction. The primary ending point will be measured three months after the second surgery. By that time the following postoperative measurements will take place (visual acuity, contrast sensitivity, twightlight vision, questionnaire included). | — |
Countries
Germany
Contacts
Public ContactAngelos Simopoulos
MVZ RHR Augenärzte GmbH Düsseldorf,Heinrich Heine Universität Düsseldorf
Outcome results
None listed